|The NMT2 nmt2 (Catalog #MBS834929) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The NMT2 antibody reacts with Human, Rat, Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s NMT2 can be used in a range of immunoassay formats including, but not limited to, Immunohistochemistry (IHC), Western Blot (WB).
WB: 1:500-2000. Researchers should empirically determine the suitability of the NMT2 nmt2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The NMT2 nmt2 product has the following accession number(s) (GI #13528864) (NCBI Accession #AAH05232.1) (Uniprot Accession #O60551). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the NMT2 antibody with the following immunoassay(s):
Immunohistochemistry (IHC) (Immunohistochemical analysis of NMT2 protein in paraffin embedded Human tonsil tissue using NMT2 antibody)
Western Blot (WB) (Western Blot analysis of HEK293T cell lysates (5 ug) transfected with either recombinant NMT2 protein (Right) or empty vector (Left) detected with NMT2 antibody)
Mouse monoclonal NMT2 antibody.
Biological Significance: N-myristoyltransferase (NMT) catalyzes the reaction of N-terminal myristoylation of many signaling proteins. It transfers myristic acid from myristoyl coenzyme A to the amino group of a protein\'s N-terminal glycine residue. Biochemical evidence indicates the presence of several distinct NMTs, varying in apparent molecular weight and /or subcellular distribution. The predicted 498-amino acid of human NMT2 protein shares 77% and 96% sequence identity with human NMT1 and mouse Nmt2 comprise two distinct families of N-myristoyltransferases. Immunogen: NMT2 antibody was raised in Mouse using full length human recombinant protein of human NMT2 produced in HEK293T cell as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing NMT2 are readily searchable from our website. Different antibodies against the same target such as NMT2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. NMT2 also interacts with the following gene(s): CASP3. The following patways have been known to be associated with this gene. Blood, Bone, Bone Marrow, Brain, Connective Tissue, Embryonic Tissue, Liver, Skin, Testis, Thyroid tissues are correlated with this protein. Abnormalities, Drug-Induced, Breast Neoplasms, Disease Models, Animal, Liver Diseases, Liver Neoplasms, Experimental, Neoplasm Metastasis, Neoplasms, Experimental, Nervous System Diseases, Pancreatic Neoplasms, Pneumonia are some of the diseases may be linked to NMT2 antibody.